• Dosing and Adminitration
  • Adverse Events
  • Severe Non-Neutropenic Toxicity

TRODELVY

Adverse Events

DOSE MODIFICATIONS CAN BE MADE AS NEEDED TO HELP MANAGE ADVERSE REACTIONS1

Adverse reaction

REFERENCES:

1. TRODELVY (sacituzumab govitecan) Summary of Product Characteristics, June 2025.